Reaktion #158454

ord-4a95e073fe7d415cb8993774ba292c23

Reaktionsgleichung

CCCC[N+](CCCC)(CCCC)CCCC.[F-]
tetra-n-butylammonium fluoride
C1CCOC1
THF
O=C1OCCN1P(=O)(Cl)N1CCOC1=O
BOP-Cl
CCOC(=O)[C@H]1CCCN(CC(O)c2ccc(C(N)=NO)cc2)C1
(3S)-ethyl 1-(2-hydroxy-2-(4-(N′-hydroxycarbamimidoyl)phenyl)ethyl)piperidine-3-carboxylate
CCOC(=O)[C@H]1CCCN(CC(O)c2ccc(C(N)=NO)cc2)C1
Intermediate 3
CCOC(=O)[C@H]1CCCN(CC(O)c2ccc(C(N)=NO)cc2)C1
(3S)-ethyl 1-(2-hydroxy-2-(4-(N′-hydroxycarbamimidoyl)phenyl)ethyl)piperidine-3-carboxylate
O=C(O)CCC1(c2cc(Cl)cc(Cl)c2)CCCCC1
3-(1-(3,5-dichlorophenyl)cyclohexyl)propanoic acid
CCN(C(C)C)C(C)C
diisopropylethyl amine
O=C(O)[C@H]1CCCN(CC(O)c2ccc(-c3noc(CCC4(c5cc(Cl)cc(Cl)c5)CCCCC4)n3)cc2)C1
(3S)-1-(2-(4-(5-(2-(1-(3,5-dichlorophenyl)cyclohexyl)ethyl)-1,2,4-oxadiazol-3-yl)phenyl)-2-hydroxyethyl)-3-piperidinecarboxylic acid
Ausbeute 76.3%

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    TemperaturThe mixture was heated to 80° C. overnight
  2. 2
    Waschenwashed with saturated aqueous NaCl solution
  3. 3
    TrocknenThe organic layer was dried (MgSO4)
  4. 4
    Filtrationfiltered
  5. 5
    Einengenconcentrated
  6. 6
    workup.DISSOLUTIONThe crude product was dissolved in acetonitrile (3 mL)
  7. 7
    workup.ADDITIONtreated with 6 N aq. HCl solution
  8. 8
    Temperaturheated to 50° C. overnight
  9. 9
    FiltrationThe mixture was filtered
  10. 10
    Sonstigepurified by HPLC (HPLC conditions: Phenomenex Luna C18 5 micron column (250×30 mm); 25-100% AcCN/water (0.1% TFA); 25 minute gradient; 30 mL/min)
  11. 11
    SonstigeIsolated fractions with the correct mass were collected
  12. 12
    Sonstigefreeze-dried overnight

Vorschrift

BOP-Cl (33.4 mg, 0.131 mmol) was added to a mixture of (3S)-ethyl 1-(2-hydroxy-2-(4-(N′-hydroxycarbamimidoyl)phenyl)ethyl)piperidine-3-carboxylate (Intermediate 3, 40 mg, 0.119 mmol), 3-(1-(3,5-dichlorophenyl)cyclohexyl)propanoic acid (35.9 mg, 0.119 mmol), and diisopropylethyl amine (0.042 mL, 0.239 mmol) in DMF (3 mL). The mixture was stirred at room temperature for 2 h, and a 1M solution of tetra-n-butylammonium fluoride in THF (0.119 mL, 0.119 mmol) was added. The mixture was heated to 80° C. overnight, diluted with ethyl acetate, and washed with saturated aqueous NaCl solution. The organic layer was dried (MgSO4), filtered and concentrated. The crude product was dissolved in acetonitrile (3 mL), treated with 6 N aq. HCl solution and heated to 50° C. overnight. The mixture was filtered, and purified by HPLC (HPLC conditions: Phenomenex Luna C18 5 micron column (250×30 mm); 25-100% AcCN/water (0.1% TFA); 25 minute gradient; 30 mL/min). Isolated fractions with the correct mass were collected and freeze-dried overnight to obtain (3S)-1-(2-(4-(5-(2-(1-(3,5-dichlorophenyl)cyclohexyl)ethyl)-1,2,4-oxadiazol-3-yl)phenyl)-2-hydroxyethyl)-3-piperidinecarboxylic acid (52 mg, 63% yield) as a white solid. HPLC retention time=3.75 minutes (Waters Sunfire C18 4.6×50 mm) eluting with 10-90% aqueous methanol with 0.1% TFA over a 4 minute gradient. LC/MS: m/e 572.16, 574.10 (M+H)+.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08822510B2uspto-grants-2014_09